Sarepta Therapeutics, Inc. (SRPT)
18.50
+1.47
(+8.63%)
USD |
NASDAQ |
Feb 06, 16:00
18.56
+0.06
(+0.32%)
After-Hours: 20:00
Sarepta Therapeutics SG&A Expense (TTM) : 527.29M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 143.05M |
| Merck & Co., Inc. | 10.73B |
| Pfizer Inc. | 13.79B |
| Keros Therapeutics, Inc. | 45.77M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |